Skip to content

Arcadia Biosciences, Inc.

RKDA

CIK 0001469443

← back to feed
Revenue (TTM)
$5.06M
−3.7% YoY Q1 May 2026
Net Income (TTM)
−$5.39M
+66.8% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.85
+66.9% YoY Q1 May 2026
Gross Margin
38.9%
Q1 May 2026
Operating Margin
-37.6%
Q1 May 2026
Net Margin
-106.5%
Q1 May 2026
Free Cash Flow (TTM)
−$9.42M
Q1 May 2026
Cash
$954K
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
2.06M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings